LRR domain of NLRX1 protein delivery by dNP2 inhibits T cell functions and alleviates autoimmune encephalomyelitis

Conclusion: These results suggest that dNP2-LRR is a novel agent, which regulates effector T cell functions and could be a promising molecule for the treatment of CNS autoimmune diseases such as multiple sclerosis.

Source: Theranostics - July 3, 2020 Category: Molecular Biology Authors: Ja-Hyun Koo, Do-Hyun Kim, Donghun Cha, Min-Jong Kang, Je-Min Choi Tags: Research Paper Source Type: research